BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14592885)

  • 1. Analysis of CD4+CD25+ cell population in the thymus from myasthenia gravis patients.
    Balandina A; Saoudi A; Dartevelle P; Berrih-Aknin S
    Ann N Y Acad Sci; 2003 Sep; 998():275-7. PubMed ID: 14592885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis.
    Balandina A; Lécart S; Dartevelle P; Saoudi A; Berrih-Aknin S
    Blood; 2005 Jan; 105(2):735-41. PubMed ID: 15454488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating CD4+CD25+ and CD4+CD25- T cells in myasthenia gravis.
    Huang Y; Pirskanen R; Ciscombe R; Link H; Lefvert AK
    Ann N Y Acad Sci; 2003 Sep; 998():318-9. PubMed ID: 14592889
    [No Abstract]   [Full Text] [Related]  

  • 4. Increase of circulating CD4+CD25+ T cells in myasthenia gravis patients with stability and thymectomy.
    Sun Y; Qiao J; Lu CZ; Zhao CB; Zhu XM; Xiao BG
    Clin Immunol; 2004 Sep; 112(3):284-9. PubMed ID: 15308122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro.
    Stephens LA; Mottet C; Mason D; Powrie F
    Eur J Immunol; 2001 Apr; 31(4):1247-54. PubMed ID: 11298351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Undiminished regulatory T cells in the thymus of patients with myasthenia gravis.
    Matsui N; Nakane S; Saito F; Ohigashi I; Nakagawa Y; Kurobe H; Takizawa H; Mitsui T; Kondo K; Kitagawa T; Takahama Y; Kaji R
    Neurology; 2010 Mar; 74(10):816-20. PubMed ID: 20211905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR9 AND CCR7 are overexpressed in CD4
    Li Q; Liu P; Xuan X; Zhang J; Zhang Y; Zhu Z; Gao F; Zhang Q; Du Y
    Muscle Nerve; 2017 Jan; 55(1):84-90. PubMed ID: 26616645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment.
    Fattorossi A; Battaglia A; Buzzonetti A; Ciaraffa F; Scambia G; Evoli A
    Immunology; 2005 Sep; 116(1):134-41. PubMed ID: 16108825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis.
    Sempowski G; Thomasch J; Gooding M; Hale L; Edwards L; Ciafaloni E; Sanders D; Massey J; Douek D; Koup R; Haynes B
    J Immunol; 2001 Feb; 166(4):2808-17. PubMed ID: 11160348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating CD4+CD25+ and CD4+CD25+ T cells in myasthenia gravis and in relation to thymectomy.
    Huang YM; Pirskanen R; Giscombe R; Link H; Lefvert AK
    Scand J Immunol; 2004 Apr; 59(4):408-14. PubMed ID: 15049785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of TNF-related apoptosis-inducing ligand and receptors and implications in thymus biology and myasthenia gravis.
    Kanatli I; Akkaya B; Uysal H; Kahraman S; Sanlioglu AD
    Neuromuscul Disord; 2017 Feb; 27(2):128-135. PubMed ID: 28012741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating CD4+CD25+ T regulatory and natural killer T cells in patients with myasthenia gravis: a flow cytometry study.
    Battaglia A; Di Schino C; Fattorossi A; Scambia G; Evoli A
    J Biol Regul Homeost Agents; 2005; 19(1-2):54-62. PubMed ID: 16178275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of Th1-type chemokine receptor CXCR3 on CD4+ T cells in myasthenia gravis patients.
    Suzuki Y; Onodera H; Tago H; Saito R; Ohuchi M; Shimizu M; Matsumura Y; Kondo T; Yoshie O; Itoyama Y
    J Neuroimmunol; 2006 Mar; 172(1-2):166-74. PubMed ID: 16427705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy.
    Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD
    J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased frequency of intrathymic regulatory T cells in patients with myasthenia-associated thymoma.
    Luther C; Poeschel S; Varga M; Melms A; Tolosa E
    J Neuroimmunol; 2005 Jul; 164(1-2):124-8. PubMed ID: 15923045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4(+) T cells in thymomas.
    Ströbel P; Helmreich M; Menioudakis G; Lewin SR; Rüdiger T; Bauer A; Hoffacker V; Gold R; Nix W; Schalke B; Elert O; Semik M; Müller-Hermelink HK; Marx A
    Blood; 2002 Jul; 100(1):159-66. PubMed ID: 12070022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations.
    Stephens LA; Mason D
    J Immunol; 2000 Sep; 165(6):3105-10. PubMed ID: 10975823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The distribution of parenchyma, follicles, and lymphocyte subsets in thymus of patients with myasthenia gravis, with special reference to remission after thymectomy.
    Mori T; Nomori H; Ikeda K; Kobayashi H; Iwatani K; Kobayashi T
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):364-8. PubMed ID: 17258565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in differentiated type of T lineage cells in the myasthenic thymus: two-color fluorocytometric analysis.
    Fujii N; Itoyama Y; Goto I
    Ann Neurol; 1990 Jun; 27(6):642-6. PubMed ID: 2113791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The thymus and myasthenia gravis.
    Taha AM; Haddad R; Allam C; Baraka A
    Middle East J Anaesthesiol; 1981 Jun; 6(2):99-112. PubMed ID: 7334939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.